| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/03/2007 | US7199225 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 04/03/2007 | US7199219 Polypeptides derived from vitamin D nuclear receptor, and their uses in particular for screening vitamin D analogues |
| 04/03/2007 | US7199162 Pretreatment before allogenic transplantation of bone marrow or haematopoietic stem cells; may be administered with other chemotherapeutic or immunosuppressive agents; antitumor and anticarcinogenic agents |
| 04/03/2007 | US7199161 Clusianon derivatives; anticarcinogenic, antitumor and viricidal agents; mixture with mitogen-activated protein (MAP) kinase inhibitors |
| 04/03/2007 | US7199153 Pharmaceutical composition comprising paracetamol and niflumic acid |
| 04/03/2007 | US7199150 Amino alcohol compounds |
| 04/03/2007 | US7199139 Medicinal compositions containing diuretic and insulin resistance-improving agent |
| 04/03/2007 | US7199116 Administering 7-oxo-dehydroepiandrosterone (DHEA) or prodrug incapable of in vivo conversion to testosterone |
| 04/03/2007 | US7199113 Inhibiting tissue factor-dependent activation of blood-coagulation factors X or IX by contacting the tissue factor with a bisphosphonate blocking agent; anticoagulation |
| 04/03/2007 | US7199100 Oligopeptides; antitumor agents, antiinflammatory agents, antiischemic agents, vision defects |
| 04/03/2007 | US7198946 Screening for agents effective in decreasing abnormal macrophages associated with amyotrophic lateral sclerosis |
| 04/03/2007 | US7198944 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 04/03/2007 | US7198913 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders |
| 04/03/2007 | US7198790 Growth differentiation factor-5 |
| 04/03/2007 | US7198788 Administering pharmaceutical formulation comprising an anti-CD26 antibody, whereby the anti- CD26 antibody binds CD26 and arrests cell cycle for therapy of cancer |
| 04/03/2007 | CA2388452C Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 04/03/2007 | CA2334904C Method and system for production and collection of lavage induced stool (lis) for chemical and biologic tests of cells |
| 04/03/2007 | CA2192822C Use of immunosuppressive agents for the treatment of schizophrenia |
| 04/03/2007 | CA2186601C New combination of a .beta.-receptor blocker and a local anaesthetic |
| 04/03/2007 | CA2177578C Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors |
| 03/29/2007 | WO2007035665A1 Use of a dpp-iv inhibitor to reduce hypoglycemic events |
| 03/29/2007 | WO2007035143A1 Stabilized protease composition |
| 03/29/2007 | WO2007034924A1 METALLO-β-LACTAMASE INHIBITOR |
| 03/29/2007 | WO2007034910A1 Medicinal composition for treating bulimia and depression accompanying bulimia |
| 03/29/2007 | WO2007034846A1 Cardiotonic agent comprising grk inhibitor |
| 03/29/2007 | WO2007034778A1 Prophylactic/therapeutic agent for sleep disorder |
| 03/29/2007 | WO2007034757A1 Remedy for amyloid diseases and drug for monitoring the same |
| 03/29/2007 | WO2007034753A1 Remedy for angiogenesis-related disease comprising chondromodulin-i as the active ingredient |
| 03/29/2007 | WO2007034188A2 Chemo-immunotherapy method |
| 03/29/2007 | WO2007034135A1 Composition comprising a nsaid and paracetamol |
| 03/29/2007 | WO2007012837A3 Compositions for treating psychiatric conditions |
| 03/29/2007 | WO2006134423A3 Methods and compositions for inducing innate immune responses |
| 03/29/2007 | WO2006122178A3 A method for modulating hla class ii tumor cell surface expression with a cytokine mixture |
| 03/29/2007 | WO2006121810A3 Trimeric ox40-immunoglobulin fusion protein and methods of use |
| 03/29/2007 | WO2005112640A3 Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 03/29/2007 | WO2005097211A3 Compositions as adjuvants to improve immune responses to vaccines and methods of use |
| 03/29/2007 | WO2005089522A3 Spermicidal and virucidal properties of various forms of sophorolipids |
| 03/29/2007 | US20070074295 Schizophrenia related gene |
| 03/29/2007 | US20070072907 Use of a pyrazole derivative for preparing medicinal products that are useful in the prevention and treatment of dyslipidaemias and of diseases related to dyslipidaemias and/or to obesity |
| 03/29/2007 | US20070072848 Combinations of at1-antagonists, amiloride or triamterine, and a diuretic |
| 03/29/2007 | US20070072814 Method and means of modulating lipid metabolism |
| 03/29/2007 | US20070072810 Agent for treating diabetes |
| 03/29/2007 | US20070072807 Method of screening compounds |
| 03/29/2007 | US20070072801 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 03/29/2007 | US20070072794 Novel genes and proteins encoded thereby |
| 03/29/2007 | US20070072256 Optical molecular sensors for cytochrome p450 activity |
| 03/29/2007 | US20070072198 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 03/29/2007 | US20070071837 Treatment of aspirin resistance with radix salviae mitiorhizae, its extract and composition |
| 03/29/2007 | US20070071834 Traditional chinese medicine preparation for cardio-cerebral blood vessel diseases and its preparing method |
| 03/29/2007 | US20070071830 Method for increasing bioavailability of lipophilic bioactive compounds |
| 03/29/2007 | US20070071824 Treatment of mucositis using N-acetylcysteine |
| 03/29/2007 | US20070071822 Film coated tablet for improved upper gastrointestinal tract safety |
| 03/29/2007 | US20070071803 Dermal penetration enhancers and drug delivery systems involving same |
| 03/29/2007 | US20070071794 Drugs for treating diabetes |
| 03/29/2007 | US20070071752 Sphingosine kinase enzyme |
| 03/29/2007 | US20070071749 Using cocktail comprising endothelial growth factor specific immunoglobulin and gemcitabine to treat and/or prevent pancreatic cancer |
| 03/29/2007 | US20070071748 Treatment with anti-vegf antibodies |
| 03/29/2007 | US20070071738 Propionibacterium P-63 for use in direct fed microbials for animal feeds |
| 03/29/2007 | US20070071730 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 03/29/2007 | US20070071718 Using endothelial growth factor specific monoclonal antibody for treatment and prevention of leukemia; immunotherapy |
| 03/29/2007 | US20070071693 Therapeutic agent and therapeutic method for periodontal diseases and pulpal diseases |
| 03/29/2007 | US20070069416 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 03/29/2007 | DE202006013518U1 Mittel zur Behandlung von neuroendokrinen gesundheitlichen Störungen Agents for the treatment of health disorders neuroendocrine |
| 03/29/2007 | DE10125882B4 Arzneimittel enthaltend Ambroxol, dessen Salze und/oder Prodrugs zusammen mit α-Liponsäure im Rahmen der Behandlung des Diabetes mellitus Medicament comprising ambroxol, its salts and / or prodrugs together with α-lipoic acid in the context of the treatment of diabetes mellitus |
| 03/29/2007 | CA2623281A1 Composition comprising a nsaid and paracetamol |
| 03/29/2007 | CA2622579A1 Use of a dpp-iv inhibitor to reduce hypoglycemic events |
| 03/29/2007 | CA2622461A1 Chemo-immunotherapy method |
| 03/29/2007 | CA2621059A1 Stabilized protease composition |
| 03/29/2007 | CA2620675A1 Metallo-.beta.-lactamase inhibitors |
| 03/28/2007 | EP1767653A1 Probe for diagnosis of marfan's syndrome and method of screening with the probe |
| 03/28/2007 | EP1767650A1 Method of screening compound directly activating glycogen synthase |
| 03/28/2007 | EP1767638A2 Mutation associated with epilepsy |
| 03/28/2007 | EP1767637A1 Mutation associated with epilepsy |
| 03/28/2007 | EP1767633A1 Novel polypeptide useful for diagnosis and treatment of cancer |
| 03/28/2007 | EP1767632A2 A method for local administration of synthetic double-stranded oligonucleotides targeting a VEGF receptor |
| 03/28/2007 | EP1767625A1 Activity regulator for interferon producing cell |
| 03/28/2007 | EP1767544A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 03/28/2007 | EP1767223A1 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases |
| 03/28/2007 | EP1767222A1 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases |
| 03/28/2007 | EP1767217A1 Agent for promoting the recovery from dysfunction after the onset of central neurological disease |
| 03/28/2007 | EP1767216A1 Drug having regulatory cell ligand contained in liposome |
| 03/28/2007 | EP1767199A2 Methods and compositions for treatment of cancer pain |
| 03/28/2007 | EP1767192A2 Cationic lipid compositions targeting angiogenic endothelial cells |
| 03/28/2007 | EP1766396A2 Method of passive immunization against disease or disorder characterized by amyloid aggregation with diminished risk of neuroinflammation |
| 03/28/2007 | EP1766015A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans |
| 03/28/2007 | EP1765997A2 Pharmaceutical composition for modulating the activity of triglyceride hydrolase |
| 03/28/2007 | EP1765821A2 Gram-positive carbapenem antibacterials and processes for their preparation |
| 03/28/2007 | EP1765405A1 Combinations comprising antimuscarinic agents and corticosteroids |
| 03/28/2007 | EP1765404A1 Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 03/28/2007 | EP1765367A1 Phospholipid compositions and methods for their preparation and use |
| 03/28/2007 | EP1765364A1 Pyrimidines, such as cytidine, in treatments for patients with bipolar disorder |
| 03/28/2007 | EP1765363A2 New compositions |
| 03/28/2007 | EP1765362A2 Compositions and methods for treatment of neovascular diseases |
| 03/28/2007 | EP1765331A1 Methods and compositions for the treatment of pulmonary diseases |
| 03/28/2007 | EP1765326A1 Carbapenem antibacterials with gram-negative activity and processes for their preparation |
| 03/28/2007 | EP1765313A2 Compounds for immunopotentiation |
| 03/28/2007 | EP1765283A2 Pharmaceutical compositions |
| 03/28/2007 | EP1765083A2 Use of il-17 in the treatment of fertility-related disorders |
| 03/28/2007 | EP1696958B1 Agents for treatment of glaucomatous retinopathy and optic neuropathy |
| 03/28/2007 | EP1545552B1 Combination therapy wherein a serotonin reuptake inhibitor is used |